These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15129777)

  • 1. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.
    Ho YJ; Pawlak CR; Guo L; Schwarting RK
    Behav Brain Res; 2004 Mar; 149(2):135-44. PubMed ID: 15129777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
    Ludwig V; Mihov Y; Schwarting RK
    Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual response profiles of male Wistar rats in animal models for anxiety and depression.
    Ho YJ; Eichendorff J; Schwarting RK
    Behav Brain Res; 2002 Oct; 136(1):1-12. PubMed ID: 12385785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of behavioral asymmetries in the elevated plus-maze and in the T-maze.
    Schwarting RK; Borta A
    J Neurosci Methods; 2005 Feb; 141(2):251-60. PubMed ID: 15661307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):167-75. PubMed ID: 11862345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats.
    Palenicek T; Votava M; Bubenikova V; Horacek J
    Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.
    Navarro JF; Maldonado E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution.
    Vorhees CV; Schaefer TL; Williams MT
    Synapse; 2007 Jul; 61(7):488-99. PubMed ID: 17415794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
    Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
    Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding.
    Piper BJ; Fraiman JB; Meyer JS
    Dev Psychobiol; 2005 Sep; 47(2):145-57. PubMed ID: 16136551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring.
    Adori C; Zelena D; Tímár J; Gyarmati Z; Domokos A; Sobor M; Fürst Z; Makara G; Bagdy G
    Behav Brain Res; 2010 Jan; 206(2):299-309. PubMed ID: 19782105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").
    Morley KC; Gallate JE; Hunt GE; Mallet PE; McGregor IS
    Eur J Pharmacol; 2001 Dec; 433(1):91-9. PubMed ID: 11755138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
    Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
    Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How various drugs affect anxiety-related behavior in male and female rats prenatally exposed to methamphetamine.
    Macúchová E; Ševčíková M; Hrebíčková I; Nohejlová K; Šlamberová R
    Int J Dev Neurosci; 2016 Jun; 51():1-11. PubMed ID: 27067624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
    Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
    Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
    Sumnall HR; O'Shea E; Marsden CA; Cole JC
    Pharmacol Biochem Behav; 2004 Apr; 77(4):805-14. PubMed ID: 15099927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
    Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
    Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.